Systematic Reviews of Selective Serotonin Reuptake Inhibitors

Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of selective serotonin reuptake inhibitors (SSRIs).

Reviewed May 2012

Printer friendly page Printer friendly page

14 Resources Found

Results 1 to 14 displayed.

Title:   Second-generation antidepressants for winter depression
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Seasonal affective disorder (winter depression) is a type of depression that recurs in the autumn and lasts until the spring. It is similar to regular depression except sufferers are usually very tired and have an increase in their appetite. It is more ...
Date:   Aug 2011
Title:   Second-generation antipsychotic drugs for obsessive compulsive disorder
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This review found some trials comparing the effects of adding second-generation antipsychotic drugs or placebo to antidepressants in obsessive compulsive disorder. There were only 11 trials on three second-generation antipsychotic drugs (olanzapine, que...
Date:   Nov 2010
Title:   Selective serotonin reuptake inhibitors for the treatment of autism spectrum disorders
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Autism spectrum disorders (ASD) are characterised by problems with social interaction and communication, as well as repetitive behaviours and limited activities and interests. Selective serotonin reuptake inhibitors (SSRIs) are a class of antidepressant...
Date:   May 2010
Title:   Antidepressants for patients with tinnitus
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Tinnitus is described as the perception of sound or noise in the absence of real acoustic stimulation, and is frequently associated with depression or depressive symptoms. Six studies matched the inclusion criteria for this review. Four evaluated three ...
Date:   Oct 2008
Title:   Sertraline versus other antidepressive agents for depression
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Depression is the fourth leading cause of disease burden worldwide and is expected to show a rising trend over the next 20 years. Depression is associated with a marked personal, social and economic morbidity, loss of functioning and productivity, and c...
Date:   Jul 2008
Title:   Escitalopram versus other antidepressive agents for depression
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Although pharmacological and psychological interventions are both effective for major depression, antidepressant drugs remain the mainstay of treatment. During the last 20 years, selective serotonin reuptake inhibitors (SSRIs) have progressively become ...
Date:   Jun 2008
Title:   Selective serotonin reuptake inhibitors for premenstrual syndrome
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Premenstrual syndrome (PMS) is a common cause of physical, behavioural, and also social dysfunction in women. Often the associated symptoms are evident as irritability, which is relieved by the onset of, or during, menstruation. PMS can severely disrupt...
Date:   Apr 2008
Title:   Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Obsessive compulsive disorder (OCD) is a common and disabling disorder, which frequently follows a chronic course. It is characterised by intrusive thoughts of imagined harm, which are difficult to dispel, and ritualistic behaviour such as repetitive wa...
Date:   Nov 2007
Title:   Amitriptyline for depression
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Amitriptyline still has a place in the pharmacological management of depressive episodes. The findings of this systematic review showed that in comparison with control agents, amitriptyline was slightly more effective, but the burden of side-effects was...
Date:   May 2007
Title:   Selective serotonin reuptake inhibitors (new generation antidepressants) for depressive disorders in children and adolescents
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Depressive disorders are common in young people and have significant negative impacts. Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for the treatment of depressive disorder in children and adolescents. The review of 12 trials ...
Date:   Mar 2007
Title:   Antidepressants for depressed older people
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   This review compared the efficacy, withdrawal rates and side effects of different antidepressant classes in the treatment of depression in older people. Thirty-two studies provided data for the review. Our main findings indicate that tricyclic antidepre...
Date:   Feb 2006
Title:   Medication, psychotherapy, or a combination of both, in treating body dysmorphic disorder
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Body dysmorphic disorder (BDD) is a condition characterised by a distressing and disabling preoccupation with an imagined or slight defect in appearance. This causes people with this disorder either significant distress or disrupts their daily functioni...
Date:   May 2004
Title:   Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine or tension-type headaches
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Migraine and tension-type headaches are common and can interfere significantly with social functioning, daily activities, and work. People with very frequent or severe headaches may benefit from preventive drug therapy. Selective serotonin re-uptake inh...
Date:   Jan 2004
Title:   Medication for social anxiety disorder
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Social phobia (SP), or social anxiety disorder, is increasingly viewed as a prevalent and disabling medical disorder. This systematic review of randomized placebo-controlled trials (RCTs) provides evidence of the efficacy of medication, and SSRIs in par...
Date:   Jul 2000

Results 1 to 14 displayed.